{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T00:56:52Z","timestamp":1787965012619,"version":"build-2784847793"},"reference-count":20,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2020,11,4]],"date-time":"2020-11-04T00:00:00Z","timestamp":1604448000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006436","name":"Celgene","doi-asserted-by":"publisher","award":["GN16RH008"],"award-info":[{"award-number":["GN16RH008"]}],"id":[{"id":"10.13039\/100006436","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["RE\/13\/5\/30177"],"award-info":[{"award-number":["RE\/13\/5\/30177"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"name":"UK Biobank resource"},{"name":"BHF Centre of Excellence","award":["RE\/13\/5\/30177"],"award-info":[{"award-number":["RE\/13\/5\/30177"]}]},{"name":"AMRA Medical AB"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,4,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>To compare body composition in PsA with metabolic disease free (MDF) controls and type 2 diabetes and assess body-composition predicted propensity for cardiometabolic disease.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Detailed MRI body composition profiles of 26 PsA participants from the IMAPA study were compared with 130 age, sex and BMI-matched MDF controls and 454 individuals with type 2 diabetes from UK Biobank. The body-composition predicted propensity for coronary heart disease (CHD) and type 2 diabetes was compared between PsA and matched MDF controls.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>PsA participants had a significantly greater visceral adipose tissue (VAT) volume [mean 5.89\u2009l (s.d. 2.10\u2009l)] compared with matched-MDF controls [mean 4.34\u2009l (s.d. 1.83\u2009l)] (P\u00a0&amp;lt;0.001) and liver fat percentage [median 8.88% (interquartile range 4.42\u201313.18%)] compared with MDF controls [3.29% (1.98\u20137.25%)] (P\u00a0&amp;lt;0.001). These differences remained significant after adjustment for age, sex and BMI. There were no statistically significant differences in VAT, liver fat or muscle fat infiltration (MFI) between PsA and type 2 diabetes. PsA participants had a lower thigh muscle volume than MDF controls and those with type 2 diabetes. Body composition-predicted propensity for CHD and type 2 diabetes was 1.27 and 1.83 times higher, respectively, for PsA compared with matched-MDF controls.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Individuals with PsA have an adverse body composition phenotype with greater visceral and ectopic liver fat and lower thigh muscle volume than matched MDF controls. Body fat distribution in PsA is more in keeping with the pattern observed in type 2 diabetes and is associated with greater propensity to cardiometabolic disease. These data support the need for greater emphasis on weight loss in PsA management to lessen CHD and type 2 diabetes risk.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/keaa604","type":"journal-article","created":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T19:39:23Z","timestamp":1598989163000},"page":"1858-1862","source":"Crossref","is-referenced-by-count":13,"title":["Psoriatic arthritis is associated with adverse body composition predictive of greater coronary heart disease and type 2 diabetes propensity \u2013 a cross-sectional study"],"prefix":"10.1093","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6136-8349","authenticated-orcid":false,"given":"Lyn D","family":"Ferguson","sequence":"first","affiliation":[{"name":"Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Linge","sequence":"additional","affiliation":[{"name":"AMRA Medical, Link\u00f6ping, Sweden"},{"name":"Department of Health, Medicine and Caring Sciences, Link\u00f6ping University, Link\u00f6ping, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olof","family":"Dahlqvist Leinhard","sequence":"additional","affiliation":[{"name":"AMRA Medical, Link\u00f6ping, Sweden"},{"name":"Department of Health, Medicine and Caring Sciences, Link\u00f6ping University, Link\u00f6ping, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosemary","family":"Woodward","sequence":"additional","affiliation":[{"name":"Glasgow Clinical Research Imaging Facility, Queen Elizabeth University Hospital, Glasgow, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline","family":"Hall Barrientos","sequence":"additional","affiliation":[{"name":"Glasgow Clinical Research Imaging Facility, Queen Elizabeth University Hospital, Glasgow, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giles","family":"Roditi","sequence":"additional","affiliation":[{"name":"Glasgow Clinical Research Imaging Facility, Queen Elizabeth University Hospital, Glasgow, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"Radjenovic","sequence":"additional","affiliation":[{"name":"Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iain B","family":"McInnes","sequence":"additional","affiliation":[{"name":"Institute of Infection, Immunity, and Inflammation, University of Glasgow, Glasgow, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1802-7311","authenticated-orcid":false,"given":"Stefan","family":"Siebert","sequence":"additional","affiliation":[{"name":"Institute of Infection, Immunity, and Inflammation, University of Glasgow, Glasgow, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naveed","family":"Sattar","sequence":"additional","affiliation":[{"name":"Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,11,4]]},"reference":[{"key":"2021040620372178900_keaa604-B1","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1136\/annrheumdis-2012-201299","article-title":"Obesity and the risk of psoriatic arthritis: a population-based study","volume":"71","author":"Love","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"2021040620372178900_keaa604-B2","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1093\/rheumatology\/kez192","article-title":"Association of central adiposity with psoriasis, psoriatic arthritis and rheumatoid arthritis: a cross-sectional study of the UK Biobank","volume":"58","author":"Ferguson","year":"2019","journal-title":"Rheumatology"},{"key":"2021040620372178900_keaa604-B3","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1161\/CIRCULATIONAHA.106.675355","article-title":"Abdominal visceral and subcutaneous adipose tissue compartments","volume":"116","author":"Fox","year":"2007","journal-title":"Circulation"},{"key":"2021040620372178900_keaa604-B4","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s12916-014-0123-4","article-title":"Type 2 diabetes as a disease of ectopic fat","volume":"12","author":"Sattar","year":"2014","journal-title":"BMC Med"},{"key":"2021040620372178900_keaa604-B5","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1002\/oby.22210","article-title":"Body composition profiling in the UK Biobank Imaging Study","volume":"26","author":"Linge","year":"2018","journal-title":"Obesity"},{"key":"2021040620372178900_keaa604-B6","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1093\/gerona\/glz229","article-title":"On the definition of sarcopenia in the presence of aging and obesity-initial results from UK Biobank","volume":"75","author":"Linge","year":"2020","journal-title":"J Gerontol A"},{"key":"2021040620372178900_keaa604-B7","first-page":"2603","article-title":"Effect of phosphodiesterase 4 inhibition with apremilast on cardiometabolic outcomes in psoriatic arthritis \u2013 Initial Results from the Immune Metabolic Associations in Psoriatic Arthritis (IMAPA) study","volume":"71(Suppl 10","author":"Ferguson","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"2021040620372178900_keaa604-B8","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1002\/art.21972","article-title":"Classification criteria for psoriatic arthritis: development of new criteria from a large international study","volume":"54","author":"Taylor","year":"2006","journal-title":"Arthritis Rheum"},{"key":"2021040620372178900_keaa604-B9"},{"key":"2021040620372178900_keaa604-B10","doi-asserted-by":"crossref","first-page":"e1001779","DOI":"10.1371\/journal.pmed.1001779","article-title":"UK Biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age","volume":"12","author":"Sudlow","year":"2015","journal-title":"PLoS Med"},{"key":"2021040620372178900_keaa604-B11","doi-asserted-by":"crossref","DOI":"10.1002\/mrm.28360","article-title":"Reproducibility and repeatability of MRI- based body composition analysis","author":"Borga","year":"2020","journal-title":"Magn Reson Med"},{"key":"2021040620372178900_keaa604-B12","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1002\/oby.22510","article-title":"Sub-phenotyping metabolic disorders using body composition: an individualized, nonparametric approach utilizing large data sets","volume":"27","author":"Linge","year":"2019","journal-title":"Obesity"},{"key":"2021040620372178900_keaa604-B13","doi-asserted-by":"crossref","first-page":"R16","DOI":"10.1186\/ar3240","article-title":"Bone mineral density and body composition in postmenopausal women with psoriasis and psoriatic arthritis","volume":"13","author":"Pedreira","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"2021040620372178900_keaa604-B14","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1159\/000254482","article-title":"Increased amount of visceral fat in patients with psoriasis contributes to metabolic syndrome","volume":"220","author":"Balci","year":"2010","journal-title":"Dermatology"},{"key":"2021040620372178900_keaa604-B15","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.jid.2017.10.024","article-title":"Risk of incident liver disease in patients with psoriasis, psoriatic arthritis, and rheumatoid arthritis: a population-based study","volume":"138","author":"Ogdie","year":"2018","journal-title":"J Invest Dermatol"},{"key":"2021040620372178900_keaa604-B16","doi-asserted-by":"crossref","first-page":"372","DOI":"10.2337\/dc17-1902","article-title":"Nonalcoholic fatty liver disease and risk of incident type 2 diabetes: a meta-analysis","volume":"41","author":"Mantovani","year":"2018","journal-title":"Diabetes Care"},{"key":"2021040620372178900_keaa604-B17","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1093\/rheumatology\/key286","article-title":"Risk of type 2 diabetes and cardiovascular disease in an incident cohort of people with psoriatic arthritis: a population-based cohort study","volume":"58","author":"Charlton","year":"2019","journal-title":"Rheumatology"},{"key":"2021040620372178900_keaa604-B18","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1001\/jama.2018.19329","article-title":"Association of genetic variants related to gluteofemoral vs abdominal fat distribution with type 2 diabetes, coronary disease, and cardiovascular risk factors","volume":"320","author":"Lotta","year":"2018","journal-title":"JAMA"},{"key":"2021040620372178900_keaa604-B19","doi-asserted-by":"crossref","first-page":"215","DOI":"10.5114\/reum.2017.71627","article-title":"Changes in body composition and bone mineral density in postmenopausal women with psoriatic arthritis","volume":"5","author":"Krajewska-W\u0142odarczyk","year":"2017","journal-title":"Reumatologia"},{"key":"2021040620372178900_keaa604-B20","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s13075-019-1810-5","article-title":"Weight loss improves disease activity in patients with psoriatic arthritis and obesity: an interventional study","volume":"21","author":"Klingberg","year":"2019","journal-title":"Arthritis Res Ther"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/60\/4\/1858\/36912802\/keaa604.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/60\/4\/1858\/36912802\/keaa604.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,6]],"date-time":"2021-04-06T23:39:33Z","timestamp":1617752373000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/60\/4\/1858\/5956232"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,4]]},"references-count":20,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2020,11,4]]},"published-print":{"date-parts":[[2021,4,6]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keaa604","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,4,1]]},"published":{"date-parts":[[2020,11,4]]}}}